inviCRO brings in $45.8M to offer its imaging services and analysis technology

By NICOLE ORAN

Feb. 26, 2016

An MRI of a brain tumor

inviCRO has raised $45.8 million in its first disclosed financing. The money will be used to offer imaging services and analysis to aid drug research and development, according to a regulatory filing.

This news comes just after the Boston-based startup acquired Molecular Neuroimaging (MNI), expanding its neurological imaging options.

As Fierce Medical Devices reported, inviCRO helped open the Translational Imaging Center in Mattawan, MI that it co-manages with MNI Research and 3D Imaging; inviCRO provides molecular imaging, while 3D imaging offers radiopharmaceutical services and MNI contributes its CRO services.

The company is continuing to expand, considering last year it also acquired a Seattle-based histology team.

Essentially the company’s goal with these acquisitions and expansion is to provide imaging that goes from exploring to tissue captures to additionally providing information for additional drug discovery and research development. MNI will help with the neurology angle.

http://medcitynews.com/2016/02/invicro-brings-in-45-8m-for-offer-its-imaging-services-and-analysis-technology/?utm_source=MedCity+News+Subscribers&utm_campaign=10f8bb7d36-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-10f8bb7d36-408817989